Published :
Tables : 60
Figures : 55
Category : Healthcare
No. of Pages : 245
Report Code : HC-U9173
Vaccine Administration Devices Market Overview: A vaccination is a chemical that is injected into the body to prevent infection or disease caused by a pathogen, such as a virus, bacteria, or parasite. By triggering an immunological reaction, the vaccine instructs the body on how to defend itself against the disease. Preventive vaccinations operate by delivering a small component or a non-harmful form of the pathogen (known as the foreign antigen) into the body, which protects the individual from infection or sickness. Antibodies (through the humoral reaction), killer cells (by the cell mediated response), or both are produced in the body in response to the pathogen. Inactivated/killed vaccinations, live/attenuated vaccines, toxoid vaccines, and conjugate vaccines are examples of vaccine types. Using a syringe or needle, vaccines are delivered intramuscularly or subcutaneously. Vaccine administration devices include features such as the development of novel vaccines, which will have an impact on manufacturers launching new products into the market, increasing demand, as well as the rising burden of infectious diseases, which leads to the demand for precise vaccine administration in order to elicit a strong immune response on delivery of targeted vaccines. Various research studies are now being conducted, which are likely to give producers with a competitive advantage in developing new and novel vaccine administration devices, as well as other opportunities in the vaccine administration devices market. The vaccine administration devices market is likely to be restrained in the forecast period due to the difficulty of mucosal delivery of vaccinations and patients' phobia of injections and needle sticks. FutureWise Market Research has instantiated a report that provides an intricate analysis of Vaccine Administration Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Vaccine Administration Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Vaccine Administration Devices Market: • BD • Terumo Europe Nv (A Subsidiary Of Terumo Corporation) • Gerresheimer AG • West Pharmaceutical Services, Inc. • Schott Ag (A Subsidiary Of Carl-zeiss-stiftung) • 3M • Antares Pharma • Bespak Europe Ltd. • Corium Inc. • D'antonio Consultants International, Inc. • Enesi • Ihealthnet Llc. • Injex Uk • Inovio Pharmaceuticals • Medical International Technologies (Mit Canada) Inc. • Micropoint Technolgies • Mylan Pharmaceuticals Inc. (A Subsidiary Of Mylan N.V.) • Mystic Pharmaceuticals • Nanopass • Pharmajet • Star Syringe Limited • Vaxxas Pty. Ltd. (Note: The list of the major players will be updated with the latest market scenario and trends) Vaccine Administration Devices Market Segmentation: By Product • Auto Injector o Intramuscular o Subcutaneous • Jet Injectors o Disposable Cartridge Jet Injector (Dcji) With Prefilled Unit Dose Cartridges o Single-use Disposable Jet Injectors (Sudji) o Disposable Cartridge Jet Injectors (Dcji): End-user Filling. o Solid Particle Jet Injectors • Micro Needles o Hollow Microneedles o Vaccine -coated Microneedles o Dissolvable/biodegradable Microneedles o Solid Microneedles • Inhalation/pulmonary Delivery o Powder Inhalation o Liquid Inhalation • Microinjection Systems • Pen-injector Devices • Biodegradable Implants • Electroporation-based Needle Free Injection Systems • Buccal / Sublingual Vaccine Delivery Systems • Auto-injector Trainer Devices • Other Devices By Route of Administration • Intramuscular Vaccination • Subcutaneous Vaccination • Intradermal Vaccination By Type • Marketed- Vaccines o Syringes o Autoinjectors • Intramuscular • Subcutaneuos o Jet Injectors o Microneedles o Aerosol/dry Powder Inhalation o Microinjection System o Biodegradable Implants o Electroporation- Based Needle Free Injection Systems o Buccal /sublingual Vaccine Delivery Systems o Others Devices • Clinical- Stage Vaccines By Brand • Bd Accuspray Nasal Spray System • Bd Hypak For Vaccines Glass Pre-fillable Syringe System • Bd Uniject Auto-disable Pre-fillable Injection System • Plajex • Gx Rtf Clearject • Gx Innosafe • Others By Vaccine Type • Bivalent Oral Polio Vaccine • Bcg Vaccine • Tetanus-diphtheria Vaccine • Dtp-hepb-hib Vaccine • Influenza Vaccine • Pneumococcal Conjugate Vaccine • Measles Vaccine • Others By Modality • Automatic Vaccine Administration Device • Manual Vaccine Administration Device By Usability • Disposable • Reusable By End User • Hospitals • Community Centers • Homecare Setting • Research And Academic Institutes • Ambulatory Surgical Center • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Vaccine Administration Devices Market By Product, By Route of Administration, By Type, By Brand, By Vaccine Type, By Modality, By Usability, By End User, and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
A vaccination is a chemical that is injected into the body to prevent infection or disease caused by a pathogen, such as a virus, bacteria, or parasite. By triggering an immunological reaction, the vaccine instructs the body on how to defend itself against the disease. Preventive vaccinations operate by delivering a small component or a non-harmful form of the pathogen (known as the foreign antigen) into the body, which protects the individual from infection or sickness. Antibodies (through the humoral reaction), killer cells (by the cell mediated response), or both are produced in the body in response to the pathogen. Inactivated/killed vaccinations, live/attenuated vaccines, toxoid vaccines, and conjugate vaccines are examples of vaccine types. Using a syringe or needle, vaccines are delivered intramuscularly or subcutaneously. Vaccine administration devices include features such as the development of novel vaccines, which will have an impact on manufacturers launching new products into the market, increasing demand, as well as the rising burden of infectious diseases, which leads to the demand for precise vaccine administration in order to elicit a strong immune response on delivery of targeted vaccines. Various research studies are now being conducted, which are likely to give producers with a competitive advantage in developing new and novel vaccine administration devices, as well as other opportunities in the vaccine administration devices market. The vaccine administration devices market is likely to be restrained in the forecast period due to the difficulty of mucosal delivery of vaccinations and patients' phobia of injections and needle sticks.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Vaccine Administration Devices Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Vaccine Administration Devices Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Vaccine Administration Devices Market: • BD • Terumo Europe Nv (A Subsidiary Of Terumo Corporation) • Gerresheimer AG • West Pharmaceutical Services, Inc. • Schott Ag (A Subsidiary Of Carl-zeiss-stiftung) • 3M • Antares Pharma • Bespak Europe Ltd. • Corium Inc. • D'antonio Consultants International, Inc. • Enesi • Ihealthnet Llc. • Injex Uk • Inovio Pharmaceuticals • Medical International Technologies (Mit Canada) Inc. • Micropoint Technolgies • Mylan Pharmaceuticals Inc. (A Subsidiary Of Mylan N.V.) • Mystic Pharmaceuticals • Nanopass • Pharmajet • Star Syringe Limited • Vaxxas Pty. Ltd. (Note: The list of the major players will be updated with the latest market scenario and trends)
Vaccine Administration Devices Market Segmentation: By Product • Auto Injector o Intramuscular o Subcutaneous • Jet Injectors o Disposable Cartridge Jet Injector (Dcji) With Prefilled Unit Dose Cartridges o Single-use Disposable Jet Injectors (Sudji) o Disposable Cartridge Jet Injectors (Dcji): End-user Filling. o Solid Particle Jet Injectors • Micro Needles o Hollow Microneedles o Vaccine -coated Microneedles o Dissolvable/biodegradable Microneedles o Solid Microneedles • Inhalation/pulmonary Delivery o Powder Inhalation o Liquid Inhalation • Microinjection Systems • Pen-injector Devices • Biodegradable Implants • Electroporation-based Needle Free Injection Systems • Buccal / Sublingual Vaccine Delivery Systems • Auto-injector Trainer Devices • Other Devices By Route of Administration • Intramuscular Vaccination • Subcutaneous Vaccination • Intradermal Vaccination By Type • Marketed- Vaccines o Syringes o Autoinjectors • Intramuscular • Subcutaneuos o Jet Injectors o Microneedles o Aerosol/dry Powder Inhalation o Microinjection System o Biodegradable Implants o Electroporation- Based Needle Free Injection Systems o Buccal /sublingual Vaccine Delivery Systems o Others Devices • Clinical- Stage Vaccines By Brand • Bd Accuspray Nasal Spray System • Bd Hypak For Vaccines Glass Pre-fillable Syringe System • Bd Uniject Auto-disable Pre-fillable Injection System • Plajex • Gx Rtf Clearject • Gx Innosafe • Others By Vaccine Type • Bivalent Oral Polio Vaccine • Bcg Vaccine • Tetanus-diphtheria Vaccine • Dtp-hepb-hib Vaccine • Influenza Vaccine • Pneumococcal Conjugate Vaccine • Measles Vaccine • Others By Modality • Automatic Vaccine Administration Device • Manual Vaccine Administration Device By Usability • Disposable • Reusable By End User • Hospitals • Community Centers • Homecare Setting • Research And Academic Institutes • Ambulatory Surgical Center • Others By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Vaccine Administration Devices Market By Product, By Route of Administration, By Type, By Brand, By Vaccine Type, By Modality, By Usability, By End User, and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Vaccine Administration Devices Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Vaccine Administration Devices Market Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Vaccine Administration Devices Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Vaccine Administration Devices Market, By Product Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Auto Injector 7.1.1. Intramuscular 7.1.2. Subcutaneous 7.2. Jet Injectors 7.2.1. Disposable Cartridge Jet Injector (Dcji) With Prefilled Unit Dose Cartridges 7.2.2. Single-use Disposable Jet Injectors (Sudji) 7.2.3. Disposable Cartridge Jet Injectors (Dcji): End-user Filling. 7.2.4. Solid Particle Jet Injectors 7.3. Micro Needles 7.3.1. Hollow Microneedles 7.3.2. Vaccine -coated Microneedles 7.3.3. Dissolvable/biodegradable Microneedles 7.3.4. Solid Microneedles 7.4. Inhalation/pulmonary Delivery 7.4.1. Powder Inhalation 7.4.2. Liquid Inhalation 7.5. Microinjection Systems 7.6. Pen-injector Devices 7.7. Biodegradable Implants 7.8. Electroporation-based Needle Free Injection Systems 7.9. Buccal / Sublingual Vaccine Delivery Systems 7.10.Auto-injector Trainer Devices 7.11.Other Devices 8. Vaccine Administration Devices Market, By Route of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Intramuscular Vaccination 8.2. Subcutaneous Vaccination 8.3. Intradermal Vaccination 9. Vaccine Administration Devices Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Marketed- Vaccines 9.1.1. Syringes 9.1.2. Autoinjectors 9.1.2.1. Intramuscular 9.1.2.2. Subcutaneuos 9.1.3. Jet Injectors 9.1.4. Microneedles 9.1.5. Aerosol/dry Powder Inhalation 9.1.6. Microinjection System 9.1.7. Biodegradable Implants 9.1.8. Electroporation- Based Needle Free Injection Systems 9.1.9. Buccal /sublingual Vaccine Delivery Systems 9.1.10.Others Devices 9.2. Clinical- Stage Vaccines 10. Vaccine Administration Devices Market, By Brand Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Bd Accuspray Nasal Spray System 10.2. Bd Hypak For Vaccines Glass Pre-fillable Syringe System 10.3. Bd Uniject Auto-disable Pre-fillable Injection System 10.4. Plajex 10.5. Gx Rtf Clearject 10.6. Gx Innosafe 10.7. Others 11. Vaccine Administration Devices Market, By Vaccine Type Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Bivalent Oral Polio Vaccine 11.2. Bcg Vaccine 11.3. Tetanus-diphtheria Vaccine 11.4. Dtp-hepb-hib Vaccine 11.5. Influenza Vaccine 11.6. Pneumococcal Conjugate Vaccine 11.7. Measles Vaccine 11.8. Others 12. Vaccine Administration Devices Market, By Modality Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Automatic Vaccine Administration Device 12.2. Manual Vaccine Administration Device 13. Vaccine Administration Devices Market, By Usability Historical Analysis and Forecast 2022-2028 (USD Million) 13.1. Disposable 13.2. Reusable 14. Vaccine Administration Devices Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million) 14.1. Hospitals 14.2. Community Centers 14.3. Homecare Setting 14.4. Research And Academic Institutes 14.5. Ambulatory Surgical Center 14.6. Others 15. North America Vaccine Administration Devices Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121 15.2.1. U.S.A 15.2.2. Canada 15.2.3. Mexico 15.3. Market Size (USD Million) Forecast for North America 2123-2128 16. Latin America Vaccine Administration Devices Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121 16.2.1. Brazil 16.2.2. Venezuela 16.2.3. Argentina 16.2.4. Rest of Latin America 16.3. Market Size (USD Million) Forecast for Latin America 2123-2128 17. Europe Vaccine Administration Devices Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121 17.2.1. Germany 17.2.2. U.K 17.2.3. France 17.2.4. Italy 17.2.5. Spain 17.2.6. Russia 17.2.7. Poland 17.2.8. Rest of Europe 17.3. Market Size (USD Million) Forecast for Europe 2123-2128 18. Asia Pacific Vaccine Administration Devices Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million) 18.1. Introduction 18.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121 18.2.1. Japan 18.2.2. China 18.2.3. India 18.2.4. Australia and New Zealand 18.2.5. ASEAN 18.2.6. Rest of Asia Pacific 18.3. Market Size (USD Million) Forecast for Asia Pacific 2123-2128 19. Middle East and Africa Market Analysis 2117-2121 and Forecast 2123-2128 (USD Million) 19.1. Introduction 19.2. Historical Market Size (USD Million) Analysis By Country, 2117-2121 19.2.1. GCC 19.2.2. Israel 19.2.3. South Africa 19.2.4. Rest of MEA 19.3. Market Size (USD Million) Forecast for MEA 2123-2128 20. Market Share Analysis and Competitive Landscape 20.1. Global Landscape - Key Players, Revenue and Presence 20.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 20.3. Global Emerging Companies 20.4. North America - Market Share Analysis and Key Regional Players 20.5. Europe - Market Share Analysis and Key Regional Players 20.6. Asia Pacific - Market Share Analysis and Key Regional Players 20.7. Global Key Player - Growth Matrix 21. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 21.1. BD 21.1.1. Company Overview 21.1.2. Product Portfolio 21.1.3. SWOT Analysis 21.1.4. Financial Overview 21.1.5. Strategic Overview 21.2. Terumo Europe Nv (A Subsidiary Of Terumo Corporation) 21.2.1. Company Overview 21.2.2. Product Portfolio 21.2.3. SWOT Analysis 21.2.4. Financial Overview 21.2.5. Strategic Overview 21.3. Gerresheimer AG 21.3.1. Company Overview 21.3.2. Product Portfolio 21.3.3. SWOT Analysis 21.3.4. Financial Overview 21.3.5. Strategic Overview 21.4. West Pharmaceutical Services, Inc. 21.4.1. Company Overview 21.4.2. Product Portfolio 21.4.3. SWOT Analysis 21.4.4. Financial Overview 21.4.5. Strategic Overview 21.5. Schott Ag (A Subsidiary Of Carl-zeiss-stiftung) 21.5.1. Company Overview 21.5.2. Product Portfolio 21.5.3. SWOT Analysis 21.5.4. Financial Overview 21.5.5. Strategic Overview 21.6. 3M 21.6.1. Company Overview 21.6.2. Product Portfolio 21.6.3. SWOT Analysis 21.6.4. Financial Overview 21.6.5. Strategic Overview 21.7. Antares Pharma 21.7.1. Company Overview 21.7.2. Product Portfolio 21.7.3. SWOT Analysis 21.7.4. Financial Overview 21.7.5. Strategic Overview 21.8. Bespak Europe Ltd. 21.8.1. Company Overview 21.8.2. Product Portfolio 21.8.3. SWOT Analysis 21.8.4. Financial Overview 21.8.5. Strategic Overview 21.9. Corium Inc. 21.9.1. Company Overview 21.9.2. Product Portfolio 21.9.3. SWOT Analysis 21.9.4. Financial Overview 21.9.5. Strategic Overview 21.10.D'antonio Consultants International, Inc. 21.10.1. Company Overview 21.10.2. Product Portfolio 21.10.3. SWOT Analysis 21.10.4. Financial Overview 21.10.5. Strategic Overview 21.11.Enesi 21.11.1. Company Overview 21.11.2. Product Portfolio 21.11.3. SWOT Analysis 21.11.4. Financial Overview 21.11.5. Strategic Overview 21.12.Ihealthnet Llc. 21.12.1. Company Overview 21.12.2. Product Portfolio 21.12.3. SWOT Analysis 21.12.4. Financial Overview 21.12.5. Strategic Overview 21.13.Injex Uk 21.13.1. Company Overview 21.13.2. Product Portfolio 21.13.3. SWOT Analysis 21.13.4. Financial Overview 21.13.5. Strategic Overview 20.14.Inovio Pharmaceuticals 20.14.1. Company Overview 20.14.2. Product Portfolio 20.14.3. SWOT Analysis 20.14.4. Financial Overview 20.14.5. Strategic Overview 20.15.Medical International Technologies (Mit Canada) Inc. 20.15.1. Company Overview 20.15.2. Product Portfolio 20.15.3. SWOT Analysis 20.15.4. Financial Overview 20.15.5. Strategic Overview 20.16.Micropoint Technolgies 20.16.1. Company Overview 20.16.2. Product Portfolio 20.16.3. SWOT Analysis 20.16.4. Financial Overview 20.16.5. Strategic Overview 20.17.Mylan Pharmaceuticals Inc. (A Subsidiary Of Mylan N.V.) 20.17.1. Company Overview 20.17.2. Product Portfolio 20.17.3. SWOT Analysis 20.17.4. Financial Overview 20.17.5. Strategic Overview 20.18.Mystic Pharmaceuticals 20.18.1. Company Overview 20.18.2. Product Portfolio 20.18.3. SWOT Analysis 20.18.4. Financial Overview 20.18.5. Strategic Overview 20.19.Nanopass 20.19.1. Company Overview 20.19.2. Product Portfolio 20.19.3. SWOT Analysis 20.19.4. Financial Overview 20.19.5. Strategic Overview 20.20.Pharmajet 20.20.1. Company Overview 20.20.2. Product Portfolio 20.20.3. SWOT Analysis 20.20.4. Financial Overview 20.20.5. Strategic Overview 20.21.Star Syringe Limited 20.21.1. Company Overview 20.21.2. Product Portfolio 20.21.3. SWOT Analysis 20.21.4. Financial Overview 20.21.5. Strategic Overview 20.22.Vaxxas Pty. Ltd. 20.22.1. Company Overview 20.22.2. Product Portfolio 20.22.3. SWOT Analysis 20.22.4. Financial Overview 20.22.5. Strategic Overview 22. Pre and Post COVID-20 Impact 22.1. Positive influence on the healthcare industry 22.2. The financial disruption of the manufacturing sector 22.3. Impact of COVID-20 on emerging companies 22.4. Significant mandates in the healthcare regulations initiated by administrations 22.5. The overall economic slowdown of the developing and developed nations 23. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics